|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 403/06 | |
| A61K 31/505 | |||
| A61P 25/00 |
| (11) | Number of the document | 3279195 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17179369.8 |
| Date of filing the European patent application | 2009-11-30 | |
| (97) | Date of publication of the European application | 2018-02-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 118796 P | 2008-12-01 | US |
| (72) |
Akireddy, Srinivisa Rao, US
Bhatti, Balwinder Singh, US
Cuthbertson, Timothy J., US
Dull, Gary Maurice, US
Miller, Craig, Harrison, US
Mitchener, JR., Joseph Pike, US
Munoz, Julio A., US
Otten, Pieter Albert, US
|
| (73) |
Oyster Point Pharma, Inc.,
202 Carnegie Center, Suite 109, Princeton, New Jersey 08540,
US
|
| (54) | SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE |
| SYNTHESIS AND NOVEL SALT FORMS OF (R)-5-((E)-2-PYRROLIDIN-3-YLVINYL)PYRIMIDINE |